没有抗凝血的治疗性血交换:单中心体验
Eduardo Zúñiga-Rodríguez1, Danna Peña1, Juliana Mantilla1
1Department of Nephrology, Fundación Cardio Infantil-La Cardio, Bogotá DC, Colombia.
概括
没有抗凝剂的膜治疗性血交换 (mTPE) 是各种疾病的安全医院程序. 这项研究发现并发症率低,支持其在临床上适用时使用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 膜治疗性血交换 (mTPE) 治疗自身免疫,神经,血液和脏疾病.
- 关于mTPE在没有抗凝剂的情况下有效性和安全性的数据有限.
- 这项研究评估了mTPE在没有抗凝剂的情况下的结果.
研究的目的:
- 评估膜治疗性血交换 (mTPE) 的安全性和有效性,当它在没有抗凝剂治疗的情况下进行时.
- 分析与非抗凝血mTPE相关的并发症率和不良事件.
主要方法:
- 使用注册表数据进行回顾性队列研究.
- 包括接受没有抗凝药的mTPE的成年患者.
- 数据从2021年10月到2022年10月在一个中心收集.
主要成果:
- 46名患者接受了385次mTPE治疗.
- 幽默性脏移植排斥是主要指示 (59.2%).
- 低并发症率 (1.3%) 和器械凝血 (2.1%),没有死亡率.
结论:
- 没有抗凝剂的膜治疗性血交换 (mTPE) 是一项安全的医院技术.
- 为了最佳地使用和监测这种疗法,需要进一步的方案.
相关概念视频
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...


